Global Sandostatin LAR Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sandostatin LAR Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Octreotide (trade name Sandostatin, among others) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone.
Sandostatin LAR report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sandostatin LAR market is projected to reach US$ 680.3 million in 2029, increasing from US$ 1238 million in 2022, with the CAGR of -6.8% during the period of 2024 to 2029. Demand from Tumors and Bleeding Esophageal Varices are the major drivers for the industry.
The Sandostatin LAR market analysis reveals a specialized segment within the pharmaceutical industry. Sandostatin LAR is a long-acting formulation of octreotide, a synthetic hormone used to treat various neuroendocrine tumors and acromegaly. The market growth is driven by the increasing prevalence of these conditions and the efficacy of Sandostatin LAR in managing symptoms and slowing tumor growth. Additionally, advancements in drug delivery technologies contribute to its popularity. However, competition from other somatostatin analogs and the high cost of treatment may impact market penetration. Despite challenges, the Sandostatin LAR market holds promise as healthcare providers prioritize personalized and targeted therapies for neuroendocrine disorders, creating opportunities for further development and investment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sandostatin LAR market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Novartis
Segment by Type
500mcg
1000mcg
Other
Tumors
Bleeding Esophageal Varices
Other
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sandostatin LAR market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sandostatin LAR, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sandostatin LAR industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sandostatin LAR in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sandostatin LAR introduction, etc. Sandostatin LAR Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Sandostatin LAR market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Sandostatin LAR report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sandostatin LAR market is projected to reach US$ 680.3 million in 2029, increasing from US$ 1238 million in 2022, with the CAGR of -6.8% during the period of 2024 to 2029. Demand from Tumors and Bleeding Esophageal Varices are the major drivers for the industry.
The Sandostatin LAR market analysis reveals a specialized segment within the pharmaceutical industry. Sandostatin LAR is a long-acting formulation of octreotide, a synthetic hormone used to treat various neuroendocrine tumors and acromegaly. The market growth is driven by the increasing prevalence of these conditions and the efficacy of Sandostatin LAR in managing symptoms and slowing tumor growth. Additionally, advancements in drug delivery technologies contribute to its popularity. However, competition from other somatostatin analogs and the high cost of treatment may impact market penetration. Despite challenges, the Sandostatin LAR market holds promise as healthcare providers prioritize personalized and targeted therapies for neuroendocrine disorders, creating opportunities for further development and investment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sandostatin LAR market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novartis
Segment by Type
500mcg
1000mcg
Other
Segment by Application
Tumors
Bleeding Esophageal Varices
Other
Segment by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sandostatin LAR market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sandostatin LAR, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sandostatin LAR industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sandostatin LAR in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sandostatin LAR introduction, etc. Sandostatin LAR Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Sandostatin LAR market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices